Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread
Influenza and Other Respiratory Viruses · 2026-06 · 20 (6)
DOI: 10.1111/irv.70273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 12.06.2026. Verfasst von Ndeye Awa Ndiaye und 21 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, Institut Pasteur de Dakar, Dakar, Senegal. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Genome, Viral. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, NIH HHS, French Ministry for Europe and Foreign Affairs.
Abstract (Originalsprache)
Background
Genomic surveillance is central to tracking SARS‐CoV‐2 evolution, variant replacement, and transmission dynamics. In Senegal, the Institut Pasteur de Dakar generated one of the largest national longitudinal SARS‐CoV‐2 genomic datasets, offering a unique view of viral spread from the first pandemic wave to the post‐Omicron period.
Aims
This study aimed to reconstruct SARS‐CoV‐2 evolution and dissemination in Senegal from March 2020 to September 2024, assess variant and Omicron sublineage dynamics, infer introduction and interregional spread patterns, and describe the national mutational landscape. Material and Methods A total of 4820 SARS‐CoV‐2 genomes generated by the Institut Pasteur de Dakar were analyzed. Lineage assignment, temporal and regional distribution, time‐scaled phylogenetics, discrete phylogeographic reconstruction, and mutation profiling were used to assess variant turnover, international seeding, intranational dissemination, and genomic diversification.
Results
Ancestral A/B lineages predominated in 2020 before replacement by Alpha and Beta in early 2021, followed by Delta in mid‐2021, which coincided with the highest case burden. From late 2021, Omicron became dominant, with rapid turnover of BA.1/BA.2, BA.4/BA.5, BQ.1.1, XBB, and BA.2.86, while later waves were smaller. Dakar contributed 64.7% of genomes and emerged as the main hub for inferred introductions and interregional spread, with Kaolack and Diourbel as secondary hubs. Major Omicron sublineages resulted from multiple introductions, mainly from Africa and Europe, with BA.1/BA.2 seeded from a broader range of continents than later lineages. Mutation profiling showed strong enrichment in Spike, with recurrent changes in ORF1a/ORF1b and nucleocapsid.
Discussion
The findings reveal repeated variant replacement, shifting international seeding routes, and a hub‐and‐spoke pattern of national dissemination centered on Dakar. Declining later waves may reflect increasing hybrid population immunity, although interpretation remains influenced by heterogeneous sequencing intensity.
Conclusions
This study provides an integrated national picture of SARS‐CoV‐2 evolution in Senegal and supports decentralized sequencing, stronger metadata capture, and routine use of genomic evidence for public health decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.
- Vaccine Research Center, Institut Pasteur de Dakar, Dakar, Senegal.
- Epidemiology, Clinical Research and Data Science Department, Institut Pasteur de Dakar, Dakar, Senegal.
- Public Health Direction, Institut Pasteur de Dakar, Dakar, Senegal.
ORCID-Profile: Ndeye Awa Ndiaye, Safiétou Sankhe, Mamadou Malado Jallow, Mouhamed Kane, Amadou Diallo, Ndeye Marième Top, Madeleine Dieng, Issa Gnasse, Cheikh Talla, Mamadou Aliou Barry, Oumar Faye, Cheikh Loucoubar, Gamou Fall, Marie Henriette Dior Ndione, Moussa Moïse Diagne, Ndongo Dia
Förderung
- Gates Foundation
- NIH HHS
- French Ministry for Europe and Foreign Affairs
- Agence Française de Développement
- Bill and Melinda Gates Foundation
- National Institutes of Health
Zitieren
APA
Ndiaye, N. A., Sankhe, S., Jallow, M. M., Kane, M., Ndour, K., Diallo, A., Mbanne, M., Top, N. M., Diop, S. M. B. S., Dieng, M., Gnasse, I., Goudiaby, D., Talla, C., Barry, M. A., Faye, O., Faye, O., Loucoubar, C., Sall, A. A., Fall, G., …, & Dia, N. (2026). Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread. Influenza and Other Respiratory Viruses, 20(6). https://doi.org/10.1111/irv.70273
Vancouver
Ndiaye NA, Sankhe S, Jallow MM, Kane M, Ndour K, Diallo A, et al. Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread. Influenza and Other Respiratory Viruses. 2026;20(6). doi:10.1111/irv.70273
BibTeX
@article{Ndiaye2026,
author = {Ndiaye, Ndeye Awa and Sankhe, Safiétou and Jallow, Mamadou Malado and Kane, Mouhamed and Ndour, Khadidiatou and Diallo, Amadou and Mbanne, Maimouna and Top, Ndeye Marième and Diop, Seynabou Mbaye Ba Souna and Dieng, Madeleine and Gnasse, Issa and Goudiaby, Debora and Talla, Cheikh and Barry, Mamadou Aliou and Faye, Oumar and Faye, Ousmane and Loucoubar, Cheikh and Sall, Amadou Alpha and Fall, Gamou and Ndione, Marie Henriette Dior and Diagne, Moussa Moïse and Dia, Ndongo},
title = {Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread},
journal = {Influenza and Other Respiratory Viruses},
year = {2026},
volume = {20},
number = {6},
doi = {10.1111/irv.70273}
}
EUVIMED